We Celebrate >600,000 Views for our 2,830 Scientific Articles in Life Sciences and Medicine

Feeds:: Posts; Comments

« FDA approves Cholbam to treat rare bile acid synthesis disorders

Application of GFP imaging in cancer – Nature.com »

We Celebrate >600,000 Views for our 2,830 Scientific Articles in Life Sciences and Medicine

March 19, 2015 by 2012pharmaceutical

We Celebrate >600,000 Views for our 2,830 Scientific Articles in Life Sciences and Medicine

Curator: Aviva Lev-Ari, PhD, RN

Top Posts >1,000 Views for all days from our Day 1:

4/12/2012 ending 2015-03-19 (Summarized)

All Time

Title	Views
Home page / Archives	187,310
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?	8,994
Our TEAM	4,070
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)	3,376
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)	3,342
Volume One: Perspectives on Nitric Oxide in Disease Mechanisms	3,041
Recent comprehensive review on the role of ultrasound in breast cancer management	3,036
Founder	2,541
Paclitaxel vs Abraxane (albumin-bound paclitaxel)	2,416
Newer Treatments for Depression: Monoamine, Neurotrophic Factor & Pharmacokinetic Hypotheses	2,380
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo	2,356
BioMed e-Series	2,355
The mechanism of action of the drug ‘Acthar’ for Systemic Lupus Erythematosus (SLE)	2,036
About	1,976
Introduction to Transdermal Drug Delivery (TDD) system and nanotechnology	1,889
Problems of vegetarianism	1,886
“The Molecular pathology of Breast Cancer Progression”	1,691
Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad	1,685
Akt inhibition for cancer treatment, where do we stand today?	1,656
VISION	1,618
Funding, Deals & Partnerships	1,599
Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation	1,447
Alternative Designs for the Human Artificial Heart: Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant Patient in the Community	1,376
Outcomes in High Cardiovascular Risk Patients: Prasugrel (Effient) vs. Clopidogrel (Plavix); Aliskiren (Tekturna) added to ACE or added to ARB	1,361
Journal PharmaceuticalIntelligence.com	1,332
Biosimilars: Intellectual Property Creation and Protection by Pioneer and by Biosimilar Manufacturers	1,287
Peroxisome proliferator-activated receptor (PPAR-gamma) Receptors Activation: PPARγ transrepression for Angiogenesis in Cardiovascular Disease and PPARγ transactivation for Treatment of Diabetes	1,281
Introduction to Tissue Engineering; Nanotechnology applications	1,275
CD47: Target Therapy for Cancer	1,269
The Centrality of Ca(2+) Signaling and Cytoskeleton Involving Calmodulin Kinases and Ryanodine Receptors in Cardiac Failure, Arterial Smooth Muscle, Post-ischemic Arrhythmia, Similarities and Differences, and Pharmaceutical Targets	1,240
FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules	1,222
Treatment Options for Left Ventricular Failure – Temporary Circulatory Support: Intra-aortic balloon pump (IABP) – Impella Recover LD/LP 5.0 and 2.5, Pump Catheters (Non-surgical) vs Bridge Therapy: Percutaneous Left Ventricular Assist Devices (pLVADs) and LVADs (Surgical)	1,219
Non-small Cell Lung Cancer drugs – where does the Future lie?	1,213
DNA Structure and Oligonucleotides	1,195
Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I	1,190
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care	1,159
Bone regeneration and nanotechnology	1,139
Clinical Trials Results for Endothelin System: Pathophysiological role in Chronic Heart Failure, Acute Coronary Syndromes and MI – Marker of Disease Severity or Genetic Determination?	1,132
Future of Calcitonin…?	1,110
Nanotechnology: Detecting and Treating metastatic cancer in the lymph node	1,110
Biosimilars: CMC Issues and Regulatory Requirements	1,104
Closing the Mammography gap	1,081
Treatment of Refractory Hypertension via Percutaneous Renal Denervation	1,062
‘Gamifying’ Drug R&D: Boehringer Ingelheim, Sanofi, Eli Lilly	1,053
Issues in Personalized Medicine in Cancer: Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing	1,016
Mitochondrial fission and fusion: potential therapeutic targets?	1,015
Transcatheter Aortic Valve Implantation (TAVI): Risky and Costly	1,009
Nanotechnology and HIV/AIDS treatment	1,004
UPDATED: PLATO Trial on ACS: BRILINTA (ticagrelor) better than Plavix® (clopidogrel bisulfate): Lowering chances of having another heart attack	1,002

Our Eight e-Books

AND

Top Authors VIEWS for all days ending 2015-03-19 (Summarized)

Top Authors for all days ending 2015-03-19 (Summarized)

All Time

Author	Views
2012pharmaceutical – Aviva Lev-Ari, PhD, RN	183,517
larryhbern – Larry H Bernstein, MD, FCAP	95,888
tildabarliya – Tilda Barliya, PhD	29,070
sjwilliamspa – Stephen J Williams, PhD	17,346
Dr. Sudipta Saha – Sudipta Saha, PhD	15,708
Dror Nir – Dror Nir, PhD	15,247
ritusaxena – Ritu Saxena, PhD	11,848

aviralvatsa – Aviral Vatsa, PhD	6,469
Demet Sag, Ph.D., CRA, GCP	5,824
zraviv06 – Ziv Raviv, PhD	4,264
anamikasarkar – Anamika Sarkar, PhD	2,739
zs22 – Zohi S. PhD	2,380
pkandala – Praboda Kandala, PhD	1,973
Alan F. Kaul, PharmD., MS, MBA, FCCP	1,662
Aashir Awan, PhD	1,229
megbaker58 – Meg Baker, PhD	1,214
jdpmdphd – Justin D Perlman, MD, PhD, FACC	750

Posted in Curation | 2 Comments

2 Responses

on March 20, 2015 at 7:54 AM | Reply Jose E S Roselino

Congratulations, and there are more views to come.

Loading...
on March 25, 2015 at 5:04 PM | Reply 2012pharmaceutical

Robbie Singh MS, MBA
Robbie
Robbie Singh MS, MBA
Expertise in Stem Cells, Regenerative Medicine, & Business

Congratulations on the success of your scientific and biomedical publication endeavor. You have indeed recruited a talented group of clinicians and scientists to write on their work and research interests. I have learned from the contributions of many of your authors. Many of us who are at various stages in our careers are perennial seekers of knowledge and the format with full-text and figures is very helpful. I wish you continued success in your endeavor.
Like Reply privately Flag as inappropriate 1 day ago

Loading...